Evolving Therapeutic Paradigm for Cardiometabolic Disease Management
Speakers: A/Prof Michael d'Emden and A/Prof Jonathan Shaw
Diabetes has been recognized as in independent risk factor for cardiovascular disease (CVD) and is often accompanied by other CVD risk factors. This clustering of risk factors for CVD and diagnosis of diabetes can present a complex management challenge. People living with diabetes are often diagnosed with CVD and its complications at a younger age. Large vessel disease, such as coronary heart disease and stroke, represent the leading cause of mortality and morbidity in people living with diabetes. Cardiometabolic disease risk factors such as uncontrolled blood glucose, hypertension and dyslipidaemia require heightened attention.
Management of dyslipidaemia is a persistent challenge in the clinical setting, with those at highest risk for CVD not always achieving appropriate lipids levels with current treatment therapies.
Can recent advances in treatments, such as PCSK9 inhibitors, change the way we manage people living with diabetes and cardiovascular disease?
Visit the ADS ADEA Conference website for more detail- http://ads-adea.org.au/industry-trade-breakfast-symposia/